These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16637974)

  • 21. Understanding results.
    Breau RH; Dahm P; Fergusson DA; Hatala R
    J Urol; 2009 Mar; 181(3):985-92. PubMed ID: 19150555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The perils with the misuse of predictive power.
    Dallow N; Fina P
    Pharm Stat; 2011; 10(4):311-7. PubMed ID: 20967762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting and reporting clinical trials with results of borderline significance.
    Hackshaw A; Kirkwood A
    BMJ; 2011 Jul; 343():d3340. PubMed ID: 21727163
    [No Abstract]   [Full Text] [Related]  

  • 25. Accurate confidence limits for stratified clinical trials.
    Lloyd CJ
    Stat Med; 2013 Sep; 32(20):3415-23. PubMed ID: 23553466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials.
    Pocock SJ; McMurray JJ; Collier TJ
    J Am Coll Cardiol; 2015 Dec; 66(22):2536-49. PubMed ID: 26653629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple logical solution to eliminate the limitations of using the number needed to treat.
    Lui KJ
    Eval Health Prof; 2004 Jun; 27(2):206-14. PubMed ID: 15140295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge of epidemiology and statistics for an ophthalmic practitioner.
    Thomas R; Muliyil J; Paul P
    J Indian Med Assoc; 2001 Oct; 99(10):561-4, 566. PubMed ID: 12018541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpretation and use of statistics in nursing research.
    Giuliano KK; Polanowicz M
    AACN Adv Crit Care; 2008; 19(2):211-22. PubMed ID: 18560290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size of treatment effects and their importance to clinical research and practice.
    Kraemer HC; Kupfer DJ
    Biol Psychiatry; 2006 Jun; 59(11):990-6. PubMed ID: 16368078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect size, confidence interval and statistical significance: a practical guide for biologists.
    Nakagawa S; Cuthill IC
    Biol Rev Camb Philos Soc; 2007 Nov; 82(4):591-605. PubMed ID: 17944619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based dermatology: number needed to treat and its relation to other risk measures.
    Manriquez JJ; Villouta MF; Williams HC
    J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based practice: how to perform and use systematic reviews for clinical decision-making.
    Kranke P
    Eur J Anaesthesiol; 2010 Sep; 27(9):763-72. PubMed ID: 20523217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of multiple ordinal endpoints.
    Häberle L; Pfahlberg A; Gefeller O
    Biom J; 2009 Feb; 51(1):217-26. PubMed ID: 19197963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.